Microsoft partners with Kaiser Permanente in electronic health record project

Share this article:
Microsoft HealthVault announces new partners in health info sharing quest
Microsoft HealthVault announces new partners in health info sharing quest

Nonprofit health maintenance organization (HMO) Kaiser Permanente has partnered with Microsoft in its push for electronic consumer-controlled health records.
 
The partnership was first announced on Monday and is slated to begin with a pilot project open to Kaiser's 156,000 employees, which will run until November.

If the pilot proves to be successful, a product linking Kaiser patient information with Microsoft's Health Vault would be offered to Kaiser's members.
 
“This is a big step for us, and our first partnership with a consumer health record supplier,” Anna-Lisa Silvestre, Kaiser's VP for online services told the New York Times.

Both Microsoft and Google, which offer platforms for electronic health record storage, have previously announced collaborative projects with health providers.

Microsoft's partners have included the Mayo Clinic and NewYork-Presbyterian Hospital. Google's partnerships have involved the Cleveland Clinic and Beth Israel Deaconess Medical Center.

Silvestre said Kaiser looked closely at Google's health record service but was particularly impressed by Microsoft's technology for protecting the privacy and security of personal data. Silvestre also noted that Microsoft and Kaiser are using the same web-based format, called a Continuity of Care Document.

Kaiser Permanente is the nation's largest nonprofit HMO with 8.7 million members in nine states and the District of Columbia.

Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?